Denali Therapeutics Inc
NASDAQ:DNLI
Revenue Breakdown
Breakdown by Geography
Denali Therapeutics Inc
Breakdown by Segments
Denali Therapeutics Inc
Total Revenue:
330.5m
USD
|
Atv:abeta Program License:
288.9m
USD
|
Cns Program License:
25m
USD
|
Ptv:pgrn Collaboration Agreement:
10m
USD
|
Option Research Services:
1.6m
USD
|